Plain Language Summary: a real-world database analysis on prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor
This Plain Language Summary of Publication from Future Oncology describes the results from a study looking at whether combining a second treatment (palbociclib) with an aromatase inhibitor helped people with HR+ breast cancer live longer.
Read the full article here.
The original article on which this plain language summary is based is titled ‘Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer’ and was published in npj breast cancer. Read the original article here.